1. Home
  2. SEPN vs REAX Comparison

SEPN vs REAX Comparison

Compare SEPN & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • REAX
  • Stock Information
  • Founded
  • SEPN 2022
  • REAX 2018
  • Country
  • SEPN United States
  • REAX United States
  • Employees
  • SEPN N/A
  • REAX N/A
  • Industry
  • SEPN
  • REAX
  • Sector
  • SEPN
  • REAX
  • Exchange
  • SEPN NYSE
  • REAX Nasdaq
  • Market Cap
  • SEPN 1.0B
  • REAX 1.1B
  • IPO Year
  • SEPN 2024
  • REAX N/A
  • Fundamental
  • Price
  • SEPN $23.30
  • REAX $4.65
  • Analyst Decision
  • SEPN Strong Buy
  • REAX Strong Buy
  • Analyst Count
  • SEPN 4
  • REAX 2
  • Target Price
  • SEPN $43.67
  • REAX $5.25
  • AVG Volume (30 Days)
  • SEPN 226.8K
  • REAX 773.3K
  • Earning Date
  • SEPN 11-20-2024
  • REAX 11-07-2024
  • Dividend Yield
  • SEPN N/A
  • REAX N/A
  • EPS Growth
  • SEPN N/A
  • REAX N/A
  • EPS
  • SEPN N/A
  • REAX N/A
  • Revenue
  • SEPN $981,000.00
  • REAX $1,095,350,000.00
  • Revenue This Year
  • SEPN N/A
  • REAX $79.06
  • Revenue Next Year
  • SEPN N/A
  • REAX $30.06
  • P/E Ratio
  • SEPN N/A
  • REAX N/A
  • Revenue Growth
  • SEPN N/A
  • REAX 81.37
  • 52 Week Low
  • SEPN $18.62
  • REAX $1.46
  • 52 Week High
  • SEPN $27.47
  • REAX $6.75
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • REAX 41.36
  • Support Level
  • SEPN N/A
  • REAX $4.83
  • Resistance Level
  • SEPN N/A
  • REAX $5.35
  • Average True Range (ATR)
  • SEPN 0.00
  • REAX 0.23
  • MACD
  • SEPN 0.00
  • REAX -0.03
  • Stochastic Oscillator
  • SEPN 0.00
  • REAX 13.59

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm. It has developed, integrated, and adopted various mobile and desktop-focused technologies to create a comprehensive offering to its agents and to assist Real with its brokerage operations. The group delivers a cloud-based platform to improve efficiencies and empower real estate agents to provide a seamless end-to-end experience for homebuyers and sellers. The company generates its maximum revenue from the United States.

Share on Social Networks: